XML 58 R47.htm IDEA: XBRL DOCUMENT v3.25.1
Segment - Net Income as Profit Measure (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
USD ($)
segment
Mar. 31, 2024
USD ($)
Segment Reporting Information [Line Items]    
Number of reporting segments | segment 1  
Revenue:    
Total revenue $ 114,473 $ 96,844
Cost of revenue:    
Intangible asset amortization - cost of revenue 2,585 2,915
Gross profit 79,508 62,468
Operating expenses:    
Total research and development 17,720 15,965
Total selling and marketing 24,454 23,782
Total general and administrative 33,808 26,210
Other income, net (4,524) (2,748)
Income tax provision (benefit) 381 (44)
Net income (loss) 7,047 (1,864)
Testing revenue    
Revenue:    
Total revenue 107,309 90,303
Cost of revenue:    
Cost of revenue 28,260 25,979
Product revenue    
Revenue:    
Total revenue 3,580 3,537
Cost of revenue:    
Cost of revenue 1,422 2,644
Biopharmaceutical and other revenue    
Revenue:    
Total revenue 3,584 3,004
Cost of revenue:    
Cost of revenue 2,698 2,838
Intangible Asset Amortization    
Operating expenses:    
Intangible asset amortization - operating expenses 622 738
Reportable Segment    
Revenue:    
Total revenue 114,473 96,844
Cost of revenue:    
Intangible asset amortization - cost of revenue 2,585 2,915
Gross profit 79,508 62,468
Operating expenses:    
Total research and development 17,720 15,965
Total selling and marketing 24,454 23,782
Total general and administrative 33,808 26,210
Other income, net (4,524) (2,748)
Income tax provision (benefit) 381 (44)
Net income (loss) 7,047 (1,864)
Reportable Segment | Research and development:    
Operating expenses:    
Compensation expense 9,748 9,085
Direct expense 4,141 3,874
Other research and development expenses 1,815 1,519
Allocation of facilities and IT expenses 2,016 1,487
Reportable Segment | Selling and marketing:    
Operating expenses:    
Compensation expense 17,635 17,622
Direct expense 710 1,138
Other selling and marketing expenses 3,853 3,414
Allocation of facilities and IT expenses 2,256 1,608
Reportable Segment | General and administrative:    
Operating expenses:    
Compensation expense 20,173 17,759
Other general and administrative expenses 21,890 15,037
Allocation of facilities and IT expenses (8,255) (6,586)
Reportable Segment | Testing revenue    
Revenue:    
Total revenue 107,309 90,303
Cost of revenue:    
Laboratory supplies and reagents expense 13,067 11,918
Sample collection expense 2,825 3,057
Compensation expense 5,611 5,215
Other cost 3,385 2,846
Allocation of facilities and IT expenses 3,372 2,943
Cost of revenue 28,260 25,979
Reportable Segment | Product revenue    
Revenue:    
Total revenue 3,580 3,537
Cost of revenue:    
Product costs 109 1,263
License fees and royalties 324 436
Other cost 792 824
Allocation of facilities and IT expenses 197 121
Cost of revenue 1,422 2,644
Reportable Segment | Biopharmaceutical and other revenue    
Revenue:    
Total revenue 3,584 3,004
Cost of revenue:    
Compensation expense 1,240 1,462
Other cost 1,044 949
Allocation of facilities and IT expenses 414 427
Cost of revenue 2,698 2,838
Reportable Segment | Intangible Asset Amortization    
Operating expenses:    
Intangible asset amortization - operating expenses $ 622 $ 738